CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

tedisamil sesquifumarate

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0

Earliest trial started Oct 1, 2004 (NCT00126061)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O
Mol. weight
925.17 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 3,7-di-(cyclopropylmethyl)-9,9-tetramethylene-3,7-diazabicyclo(3.3.1)nonane
  • kc 8857
  • kc-8857
  • kc-8857
  • kc-8857
  • kc-8857
  • kc-8857
  • tedisamil
  • tedisamil
  • tedisamil
  • tedisamil
  • tedisamil
  • tedisamil sesquifumarate
  • tedisamil sesquifumarate
  • tedisamil sesquifumarate
  • tedisamil sesquifumarate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00126022Phase 3Dec 1, 2004Solvay
NCT00126061Phase 3Oct 1, 2004Solvay
NCT00126074Phase 3Oct 1, 2004Solvay
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SolvayFor profit3312004
1 organizations
Page 1 / 1